To further verify the role of lncROPM and PLA2G16 on drug resistance of breast cancer, the effects of lncROPM and PLA2G16 on BCSCs survival in response to chemotherapeutic drugs were investigated. The gene discussed is PLAAT3; the disease is breast carcinoma.